Last reviewed · How we verify
salivary sample
At a glance
| Generic name | salivary sample |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Analytical Evaluation of the Endotest® Diagnostic (NA)
- High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear.
- PMPR and Chlorhexidine on Periodontal Disease and Vascular Function (NA)
- MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease (NA)
- Circadian Rhythm Deregulation in Patients With CAPS (NA)
- OUD Smartphone Services (NA)
- MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer (PHASE2)
- Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- salivary sample CI brief — competitive landscape report
- salivary sample updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI